T3D Therapeutics
Durham
About T3D Therapeutics
T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation' and neurodegeneration of Alzheimer's disease and helps in treating multiple manifestations of the disease, providing Alzheimer patients with a drug to potentially improve multiple defects and improve memory, motor function and cognition. T3D Therapeutics is based in Durham, North Carolina, and was founded in 2013.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $40.3M
- Last round: Series Unknown (Sep 2022)
- Website: t3dtherapeutics.com
- Phone: 919-237-4897
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/t3d-therapeutics-20531 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.